Growth Metrics

Boston Scientific (BSX) Shareholder's Equity Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.30%
Dec 31, 2025 11.31%
Sep 30, 2025 12.76%
Jun 30, 2025 -452.20%
Mar 31, 2025 66,117.65%
Dec 31, 2024 11.47%
Sep 30, 2024 9.55%
Jun 30, 2024 107.06%
Dec 31, 2023 2,704.00%
Sep 30, 2023 8.44%
Dec 31, 2022 66.68%
Sep 30, 2022 7.16%
Mar 31, 2022 117,800.00%
Sep 30, 2021 5.77%
Mar 31, 2021 100.99%
Sep 30, 2020 349.06%
Jun 30, 2020 107.63%
Mar 31, 2020 73.70%
Dec 31, 2019 -98.44%
Sep 30, 2019 -25,096.00%
Jun 30, 2019 0.00%
Mar 31, 2019 -137.99%
Dec 31, 2018 108,312.50%
Sep 30, 2018 -99.67%
Jun 30, 2018 -123.73%
Mar 31, 2018 143.64%
Dec 31, 2017 100.93%
Sep 30, 2017 17.06%
Jun 30, 2017 16.32%
Mar 31, 2017 9.23%
Dec 31, 2016 -2,051.14%
Sep 30, 2016 1.12%
Jun 30, 2016 -5.47%
Mar 31, 2016 -0.68%
Dec 31, 2015 -99.47%
Sep 30, 2015 -4.34%
Jun 30, 2015 0.55%
Mar 31, 2015 -0.51%
Dec 31, 2014 104,293.75%
Sep 30, 2014 2.10%
Jun 30, 2014 -0.89%
Mar 31, 2014 0.48%
Dec 31, 2013 101.47%
Sep 30, 2013 -3.88%
Jun 30, 2013 -14.56%
Mar 31, 2013 -42.94%
Dec 31, 2012 -691.30%
Sep 30, 2012 -40.73%
Jun 30, 2012 -33.03%
Mar 31, 2012 0.24%
Dec 31, 2011 -6.98%
Sep 30, 2011 4.38%
Jun 30, 2011 5.94%
Mar 31, 2011 5.45%
Dec 31, 2010 -200.00%
Sep 30, 2010 -16.99%
Jun 30, 2010 -18.79%